Ann Libs, WHNP | |
851 E 5th St, Suite 200, Washington, MO 63090-3135 | |
(636) 239-8585 | |
(636) 239-8553 |
Full Name | Ann Libs |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Women's Health |
Location | 851 E 5th St, Washington, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114029386 | NPI | - | NPPES |
1114029386 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 209004733 (Illinois) | Secondary |
363LW0102X | Nurse Practitioner - Women's Health | 2008012476 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ann Libs, WHNP 851 E 5th St, Suite 200, Washington, MO 63090-3135 Ph: (636) 239-8585 | Ann Libs, WHNP 851 E 5th St, Suite 200, Washington, MO 63090-3135 Ph: (636) 239-8585 |
News Archive
EpiCept Corporation announced today that it has entered into a definitive agreement with a single life science focused institutional investor for the purchase of 1,065 shares of its new Series B 0% Convertible Preferred Stock at $1,000 per share, which are convertible into an aggregate of approximately 6.3 million shares of its common stock, and five-year warrants to purchase up to approximately 3.1 million shares of its common stock at an exercise price of $0.17 per share that are immediately exercisable.
New research further illuminates the heart-healthy benefits of the Mediterranean diet, tying the eating plan to lower levels of platelets and white blood cells, two markers of inflammation. Inflammation has an association with greater risk of heart attack and stroke.
Reuters reports a softening in demand for hospital chains and device makers, among others. Meanwhile, law enforcement officials warn of insurance scams that play on confusion over the health care overhaul.
Kids with Pompe disease fail because of a missing enzyme, GAA, that leads to dangerous sugar build-up, which affects muscles and movement. An enzyme replacement treatment pioneered at Duke University has saved many lives, but some children with Pompe disease produce an immune reaction that blocks the benefits of the life-saving enzyme treatment.
› Verified 3 days ago